Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rajendra Prasad Vvs"'
Autor:
Sri Nataraj Kalakonda, Srinivasa Rao Atla, Roja Naveena Puvvada, Prapul Kumar Nalli, Ijaz Sheik, Rajendra Prasad VVS
Publikováno v:
International Journal of Pharmaceutical Investigation. 13:206-214
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :166-169
Objective: The objective of the study was to synthesize and evaluate the anticancer activity of some novel acridine derivatives. Methods: The present works involve condensation of acridine and various 2, 4-Thiazolidine-2,4-dione derivatives (2a–2h)
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :78-85
Objective: A series of novel synthesis of 5-Substituted-3-phenyl-4,5-dihydro-pyrazole-1-carbothioic acid [4-(9, 10-dihydro-acridin-9-yl)-phenyl]- amide (IV) were synthesized using standard procedures and evaluated for cytotoxic studies. Methods: 9-(4
Publikováno v:
International Journal of Pharmacy and Pharmaceutical Sciences. :48-54
Objective: The involvement of Janus kinase2/signal transducer and activator of transcription (JAK2/STAT3) pathway reported in various solid tumors made authors study the conformational changes of JAK2-3e complex which was previously reported with a m
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :174-179
Objective: In this study, a series of novel 2,3-disubstituted quinazolines (4a-4l) were synthesized using standard procedures and elucidated through different spectroscopic techniques. Methods: Obtained compounds were evaluated for their cytotoxicity
Autor:
Harathi Perka, Rajendra Prasad Vvs, Mani Chandrika Paturi, Deepak Reddy Gade, Siva Jyothi Buggana
Publikováno v:
Computational biology and chemistry. 79
Recent studies reported the involvement of JAK2/STAT3 pathway in various solid tumours including breast, ovarian, prostate and lung cancers. Clinical literature also reported the lowered burden in breast and ovarian cancers by targeting JAK2 pathway.
Autor:
Gade DR; Centre for Molecular Cancer Research (CMCR), Vishnu Institute of Pharmaceutical Education and Research, Narsapur, India., Makkapati A; Clinical Research Department, Emcure Pharmaceuticals Ltd., Pune, India., Yarlagadda RB; Department of Pharmaceutical Chemistry, Sultan Ul Uloom College of Pharmacy, Hyderabad, India., Peters GJ; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Sastry BS; Department of Pharmaceutical Chemistry, Gland Institute of Pharmaceutical Sciences, Narsapur, India., Rajendra Prasad VVS; Centre for Molecular Cancer Research (CMCR), Vishnu Institute of Pharmaceutical Education and Research, Narsapur, India; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: rajendraprasad.vvs@viper.ac.in.
Publikováno v:
Computational biology and chemistry [Comput Biol Chem] 2018 Jun; Vol. 74, pp. 63-75. Date of Electronic Publication: 2018 Feb 24.